Brief: Hybrigenics launches phase II study of Inecalcitol
19/01/2015 17:03
Jan 19 (Reuters) - Hybrigenics SA ALHYG.PA :
* Launches phase II study of Inecalcitol in chronic myeloid
leukemia
Source text for Eikon: ID:nFWN0UY01R
Further company coverage: ALHYG.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Keywords: HYBRIGENICS
Recent news on Aton SA
See all newsBrief: Hybrigenics SA Says Hybrigenics Re-Brands To 'Aton', Commits EUR 15Million To Support Its New Growth And Development Strategy Over Next Three Years
Brief: Hybrigenics 2022 Net Loss EUR 0.5 Million
Brief: Hybrigenics Presents Progress Of B Cell Design Subsidiary
Brief: Hybrigenics Targets EUR 60 Mln Of Turnover By 2025
Brief: Hybrigenics H1 Operating Loss Widens To EUR 0.2 Million